Literature DB >> 8800132

Role of oxidative stress in transition of hypertrophy to heart failure.

A K Dhalla1, M F Hill, P K Singal.   

Abstract

OBJECTIVES: In an attempt to define the role of increased oxidative stress in the transition from compensatory hypertrophy to heart failure, this study examined the effects of long-term vitamin E therapy on the occurrence of heart failure subsequent to chronic pressure overload in guinea pigs.
BACKGROUND: Hyperfunctional heart hypertrophy has been shown to be accompanied by an increase in the endogenous antioxidant reserve, whereas congestive heart failure is accompanied by a decrease in this reserve. The effects of vitamin E, a naturally occurring antioxidant, on the development of heart failure from a hypertrophic stage were examined.
METHODS: The ascending aorta in guinea pigs was coarcted. For vitamin treatment, slow-release pellets were implanted at the time of the operation. The animals were assessed at 10 and 20 weeks for hemodynamic function, myocardial structure, antioxidant agents and oxidative stress.
RESULTS: Banding of the ascending aorta in guinea pigs resulted in hyperfunctional hypertrophy at 10 weeks, which was followed by congestive heart failure at 20 weeks. Hypertrophied hearts showed decreased oxidative stress, as evidenced by a higher oxidation-reduction (redox) state and less lipid peroxidation, whereas the failure stage was characterized by increased oxidative stress. Supplementation of animals with timed-release vitamin E tablets resulted in an increased myocardial content of the vitamin, and the banded animals did not develop any signs of heart failure at 20 weeks. Hemodynamic function at 20 weeks in these vitamin E-treated animals was also better maintained. The myocardial reduced glutathione/oxidized glutathione ratio of vitamin E-treated animals at 20 weeks was higher and lipid peroxidation was less compared with the untreated animals. Ultrastructural abnormalities were significantly less in the vitamin E-treated hearts compared with the untreated failing hearts at 20 weeks.
CONCLUSIONS: An improved myocardial redox state with vitamin E therapy, coupled with the modulation of the development of heart failure, may indicate a pathophysiologic role for increased oxidative stress in the pathogenesis of heart failure. This study suggests the potential therapeutic value of long-term antioxidant treatment in modulating or preventing the pathogenesis of heart failure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800132     DOI: 10.1016/0735-1097(96)00140-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  86 in total

Review 1.  Molecular and cellular mechanisms of myocardial remodeling.

Authors:  Melanie Maytin; Wilson S Colucci
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

Review 2.  Statins and the role of nitric oxide in chronic heart failure.

Authors:  Stephan von Haehling; Stefan D Anker; Eberhard Bassenge
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

Review 3.  NO/redox disequilibrium in the failing heart and cardiovascular system.

Authors:  Joshua M Hare; Jonathan S Stamler
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 4.  NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology.

Authors:  Alison Cave; David Grieve; Sofian Johar; Min Zhang; Ajay M Shah
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 5.  The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox.

Authors:  Demetrios Moris; Michael Spartalis; Eleftherios Spartalis; Georgia-Sofia Karachaliou; Georgios I Karaolanis; Gerasimos Tsourouflis; Diamantis I Tsilimigras; Eleni Tzatzaki; Stamatios Theocharis
Journal:  Ann Transl Med       Date:  2017-08

6.  Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia.

Authors:  Crystal M Reynolds; Hagir B Suliman; John W Hollingsworth; Karen E Welty-Wolf; Martha Sue Carraway; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2008-11-27       Impact factor: 7.376

Review 7.  X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca²⁺]i.

Authors:  Benjamin L Prosser; Ramzi J Khairallah; Andrew P Ziman; Christopher W Ward; W J Lederer
Journal:  J Mol Cell Cardiol       Date:  2012-12-06       Impact factor: 5.000

8.  Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice.

Authors:  Fuzhong Qin; Shannon Lennon-Edwards; Steve Lancel; Andreia Biolo; Deborah A Siwik; David R Pimentel; Gerald W Dorn; Y James Kang; Wilson S Colucci
Journal:  Circ Heart Fail       Date:  2009-12-16       Impact factor: 8.790

Review 9.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

10.  Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress.

Authors:  M Nonaka-Sarukawa; K Yamamoto; H Aoki; H Takano; T Katsuki; U Ikeda; K Shimada
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.